SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $20,905,264 |
| Positions | 35 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CUE BIOPHARMA INC | CUE | COM | $1,670,408 | 52,928 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $1,489,816 | 4,450 |
| MOONLAKE IMMUNOTHERAPEUTICS | MLTX | CLASS A ORD | $1,314,225 | 67,500 |
| FENNEC PHARMACEUTICALS INC | FENC | COM | $1,208,666 | 112,434 |
| ROYALTY PHARMA PLC | RPRX | SHS CLASS A | $1,199,898 | 21,400 |
| COMPASS PATHWAYS PLC | CMPS | SPONSORED ADS | $1,132,000 | 80,000 |
| MILESTONE PHARMACEUTICALS IN | MIST | COM | $1,098,800 | 820,000 |
| BENITEC BIOPHARMA INC | BNTC | COM NEW | $829,560 | 62,000 |
| SYNDAX PHARMACEUTICALS INC | SNDX | COM | $786,960 | 36,000 |
| BIOHAVEN LTD | BHVN | COM | $769,296 | 51,700 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.